Andrew J Bradley
Affiliation: Eli Lilly and Company
- A randomised controlled study of risperidone and olanzapine for schizophrenic patients with neuroleptic-induced acute dystonia or parkinsonismH Y Chan
Department of General Psychiatry, Taoyuan Mental Hospital, Taoyuan, Taiwan
J Psychopharmacol 24:91-8. 2010..Double-blinded, fixed dose and different ethnical study for EPS-intolerant schizophrenic patients is needed to confirm the results of our study...
- Does adding noradrenaline reuptake inhibition to selective serotonin reuptake inhibition improve efficacy in patients with depression? A systematic review of meta-analyses and large randomised pragmatic trialsAndrew J Bradley
Eli Lilly and Co Ltd, Basingstoke, UK
J Psychopharmacol 27:740-58. 2013....
- A systematic review of hypothalamic-pituitary-adrenal axis function in schizophrenia: implications for mortalityAndrew J Bradley
Eli Lilly and Company Ltd, Basingstoke, UK
J Psychopharmacol 24:91-118. 2010..It is likely that this contributes to the pattern of poor physical health and premature mortality suffered by people with schizophrenia, in particular the high rates of cardiovascular and metabolic disturbance...
- Schizophrenia and breast cancer incidence: a systematic review of clinical studiesChris J Bushe
Eli Lilly and Company Ltd, Lilly House, Priestly Road, Basingstoke RG24 9NL, UK
Schizophr Res 114:6-16. 2009..We undertook a systematic review of published data to investigate possible reasons for the variable findings...